PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

SCWorx Corp.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from SCWorx Corp.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 98% of Healthcare companies in United States.
  • Tangible Assets Ratio: Of every $100 the company owns, $26 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 95% of Healthcare companies in United States.
  • Cash Cushion Ratio: Cash, after subtracting all debt, is 1.2 times its market value (net cash). Higher than 90% of Healthcare companies in United States.

Where $100 of sales goes

$133Operating costs$104Interest$154Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

0/3 · 1/3

Sales grew in 0 of the last 3 years; profit grew in 1 of 3.

Less steady than 86% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 29%

Sales fell 29% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-29% / -15%

In 3 years sales changed by -29% while total assets changed by -15%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-1,003.0×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 98% of Healthcare companies in United States.

Cash Cushion Ratio

1.2× cash

Cash, after subtracting all debt, is 1.2 times its market value (net cash).

Higher than 90% of Healthcare companies in United States.

Tangible Assets Ratio

26%

Of every $100 the company owns, $26 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 95% of Healthcare companies in United States.

Tangible Net Worth Ratio

18%

Of every $100 of net worth, $18 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 66% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+52%

Share count rose 52% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 58% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

SCWorx Corp. made a loss over the last year. SCWorx Corp. owes $0.10 for every $1 it owns. SCWorx Corp. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

SCWorx Corp. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

0.20

The share price is 0.20 times SCWorx Corp.'s book value per share, lower than 98% of Healthcare companies in United States.

Market cap

$1 M

The total market value of all of SCWorx Corp.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in United States. PosiCap size class: Nano Cap.

Net worth (book value)

$7 M

What SCWorx Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$12.85

Net worth divided by the number of shares. The share price of $2.61 is 0.2 times this, which is the P/B above.

Return on equity (ROE)

-38.1%

SCWorx Corp. lost 38.1% of its shareholders' money over the last year, higher than 56% of Healthcare companies in United States.

Owes vs Owns

0.10×

SCWorx Corp. owes $0.10 for every $1 it owns (low), lower than 87% of Healthcare companies in United States.

Dividend yield

None

SCWorx Corp. does not currently pay a dividend.

Revenue growth

-4%

Revenue fell 4% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Profit growth

Loss

SCWorx Corp. made a loss in each of the last two years.

Profit margin

-154.4%

SCWorx Corp. lost $154 for every $100 of revenue.

Interest cover

Not covered

SCWorx Corp.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

SCWorx Corp. held $2 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For SCWorx Corp.: $1 M ÷ $7 M (30 Jun 2026) = 0.2.

What is SCWorx Corp.'s return on equity?

SCWorx Corp. lost 38.1% of its shareholders' money over the last year, higher than 56% of Healthcare companies in United States.

How much does SCWorx Corp. owe compared with what it owns?

SCWorx Corp. owes $0.10 for every $1 it owns (low), lower than 87% of Healthcare companies in United States.

Does SCWorx Corp. pay a dividend?

No. SCWorx Corp. does not currently pay a dividend.

Is SCWorx Corp.'s revenue growing?

Revenue fell 4% in the year to Dec 2025, and shrank 11% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.